SCHEMBL564692

SCHEMBL564692

N#Cc1cc(I)c(Cl)nc1Cl

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.46
ALDH1A1 P00352 2/20 0.44
NPSR1 Q6W5P4 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
TDP1 Q9NUW8 1/20 0.38
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
PKM P14618 1/20 0.36
POLB P06746 1/20 0.35
CSNK1A1 P48729 1/20 0.34
CLK4 Q9HAZ1 1/20 0.34
MAPK1 P28482 1/20 0.33
CYP11B2 P19099 1/20 0.33
CHUK O15111 1/20 0.33
PGK1 P00558 1/20 0.33
TRPV4 Q9HBA0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL566209 0.84 KHK (0.57) KHKSMN1; SMN2ALDH1A1NPSR1CYP1A2
SCHEMBL20599441 0.82 NPSR1 (0.46) KHKSMN1; SMN2ALDH1A1NPSR1CYP1A2
SCHEMBL12682590 0.82 KHK (0.62) KHKSMN1; SMN2ALDH1A1NPSR1CYP1A2
SCHEMBL17647242 0.77 ALDH1A1 (0.45) KHKSMN1; SMN2ALDH1A1NPSR1CYP1A2
SCHEMBL30232391 0.77 KHK (0.52) KHKSMN1; SMN2ALDH1A1NPSR1CYP1A2
SCHEMBL566195 0.77 KHK (0.52) KHKSMN1; SMN2ALDH1A1NPSR1CYP1A2
SCHEMBL8778840 0.74 KHK (0.48) KHKSMN1; SMN2ALDH1A1NPSR1CYP1A2
SCHEMBL29448448 0.74 KHK (0.69) KHKSMN1; SMN2ALDH1A1NPSR1CYP1A2
SCHEMBL29448447 0.74 KHK (0.69) KHKSMN1; SMN2ALDH1A1NPSR1CYP1A2
SCHEMBL165776 0.74 KHK (0.69) KHKSMN1; SMN2ALDH1A1NPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3689875-B1 USE OF TRIAZOLOPYRIMIDINE, TRIAZOLOPYRIDINE COMPOUNDS AND COMPOSITION THEREOF FOR TREATING PRC2-MEDIATED DISEASES SHANGHAI INST MATERIA MEDICA CAS (CN) 2021-10-13 EP disclosed
US-9499570-B2 Boron containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2016-11-22 US disclosed
US-20150376210-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, LLC 2015-12-31 US disclosed
US-9145429-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2015-09-29 US disclosed
US-20140200198-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2014-07-17 US disclosed
US-8716478-B2 Boron-containing small molecules ANACOR PHARMACEUTICALS, INC. (US) 2014-05-06 US disclosed
US-20120035132-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC. (US) 2012-02-09 US disclosed
WO-2011094450-A1 BORON-CONTAINING SMALL MOLECULES ANACOR PHARMACEUTICALS, INC (US) 2011-08-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140200198-A1 BORON-CONTAINING SMALL MOLECULES BTD, BCL6B, BBOX1 KHK 4877/4885SMN1; SMN2 1603/4885ALDH1A1 3735/4885
US-20120035132-A1 BORON-CONTAINING SMALL MOLECULES BTD, BCL6B, BBOX1 KHK 4877/4885SMN1; SMN2 1603/4885ALDH1A1 3735/4885
US-20150376210-A1 BORON-CONTAINING SMALL MOLECULES BTD, BCL6B, BBOX1 KHK 4877/4885SMN1; SMN2 1603/4885ALDH1A1 3735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.